{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:18:47Z","timestamp":1777421927569,"version":"3.51.4"},"reference-count":29,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.3892\/mmr.2013.1834","type":"journal-article","created":{"date-parts":[[2013,11,28]],"date-time":"2013-11-28T14:10:57Z","timestamp":1385647857000},"page":"443-449","source":"Crossref","is-referenced-by-count":22,"title":["Valproic acid inhibits tumor angiogenesis in mice transplanted with Kasumi-1 leukemia cells"],"prefix":"10.3892","volume":"9","author":[{"given":"ZHI-HUA","family":"ZHANG","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CHANG-LAI","family":"HAO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PENG","family":"LIU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XIA","family":"TIAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LI-HONG","family":"WANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LEI","family":"ZHAO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CUI-MIN","family":"ZHU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2013,11,28]]},"reference":[{"key":"key20180108012847_b1-mmr-09-02-0443","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1158\/0008-5472.CAN-06-3360","article-title":"Targeting the oligomerization domain of ETO interferes with RUNX1\/ETO oncogenic activity in t(8;21)-positive leukemic cells","volume":"67","author":"Wichmann","year":"2007","journal-title":"Cancer Res"},{"key":"key20180108012847_b2-mmr-09-02-0443","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1038\/sj.onc.1204336","article-title":"Histone deacetylases: a common molecular target for differentiation treatment of acute myeloid leukemias?","volume":"20","author":"Minucci","year":"2001","journal-title":"Oncogene"},{"key":"key20180108012847_b3-mmr-09-02-0443","doi-asserted-by":"crossref","first-page":"7185","DOI":"10.1128\/MCB.18.12.7185","article-title":"Aberrant recruitment of the nuclear receptor corepressor-histone deacetylase complex by the acute myeloid leukemia fusion partner ETO","volume":"18","author":"Gelmetti","year":"1998","journal-title":"Mol Cell Biol"},{"key":"key20180108012847_b4-mmr-09-02-0443","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1038\/sj.onc.1207674","article-title":"ETO interacting proteins","volume":"23","author":"Hug","year":"2004","journal-title":"Oncogene"},{"key":"key20180108012847_b5-mmr-09-02-0443","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1600-0609.1998.tb01027.x","article-title":"Characterization of the ETO and AML1-ETO proteins involved in 8;21 translocation in acute myelogenous leukemia","volume":"60","author":"Le","year":"1998","journal-title":"Eur J Haematol"},{"key":"key20180108012847_b6-mmr-09-02-0443","doi-asserted-by":"crossref","first-page":"7176","DOI":"10.1128\/MCB.18.12.7176","article-title":"ETO, a target of t(8;21) in acute leukemia, interacts with the N-CoR and mSin3 corepressors","volume":"18","author":"Lutterbach","year":"1998","journal-title":"Mol Cell Biol"},{"key":"key20180108012847_b7-mmr-09-02-0443","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1093\/jnci\/92.15.1210","article-title":"Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells","volume":"92","author":"Marks","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"key20180108012847_b8-mmr-09-02-0443","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1182\/blood.V94.2.417","article-title":"Chromatin remodeling and leukemia: new therapeutic paradigms","volume":"94","author":"Redner","year":"1999","journal-title":"Blood"},{"key":"key20180108012847_b9-mmr-09-02-0443","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1124\/pr.56.4.3","article-title":"Vascular endothelial growth factor and angiogenesis","volume":"56","author":"Hoeben","year":"2004","journal-title":"Pharmacol Rev"},{"key":"key20180108012847_b10-mmr-09-02-0443","doi-asserted-by":"crossref","first-page":"132641","DOI":"10.1155\/2010\/132641","article-title":"Tumor angiogenesis: insights and innovations","volume":"2010","author":"Nussenbaum","year":"2010","journal-title":"J Oncol"},{"key":"key20180108012847_b11-mmr-09-02-0443","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0006-2952(03)00411-8","article-title":"Antitumor efficacy of FK228, a novel histone deacetylase inhibitor, depends on the effect on expression of angiogenesis factors","volume":"66","author":"Sasakawa","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"key20180108012847_b12-mmr-09-02-0443","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","article-title":"Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells","volume":"20","author":"G\u00f6ttlicher","year":"2001","journal-title":"EMBO J"},{"key":"key20180108012847_b13-mmr-09-02-0443","first-page":"802","article-title":"Inhibitory effect of valproic acid on cell cycle of Kasumi-1 cell line and its mechanism","volume":"29","author":"Zhao","year":"2008","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"key20180108012847_b14-mmr-09-02-0443","first-page":"466","article-title":"Effects of histone deacetylase inhibitor on the expression of angiogenesis related factors in Kasumi-1 leukemic cell line","volume":"31","author":"Zhu","year":"2010","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"key20180108012847_b15-mmr-09-02-0443","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1200\/JCO.2002.07.089","article-title":"Tumor microvessel density as a predictor of recurrence after resection of hepatocellular carcinoma: a prospective study","volume":"20","author":"Poon","year":"2002","journal-title":"J Clin Oncol"},{"key":"key20180108012847_b16-mmr-09-02-0443","first-page":"9","article-title":"Intratumor microvessel density as a prognostic factor in cancer","volume":"147","author":"Weidner","year":"1995","journal-title":"Am J Pathol"},{"key":"key20180108012847_b17-mmr-09-02-0443","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/10428190400007565","article-title":"The Kasumi-1 cell line: a t(8;21)-kit mutant model for acute myeloid leukemia","volume":"46","author":"Larizza","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"key20180108012847_b18-mmr-09-02-0443","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1124\/jpet.106.118406","article-title":"Targeting AML1\/ETO-histone deacetylase repressor complex: a novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1\/ETO-positive acute myeloid leukemia cells","volume":"321","author":"Liu","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"key20180108012847_b19-mmr-09-02-0443","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/10428190500270386","article-title":"Disease-specific expression of VEGF and its receptors in AML cells: possible autocrine pathway of VEGF\/type1 receptor of VEGF in t(15;17) AML and VEGF\/type2 receptor of VEGF in t(8;21) AML","volume":"47","author":"Hiramatsu","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"key20180108012847_b20-mmr-09-02-0443","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1365-2141.2006.06372.x","article-title":"t(8;21) acute myeloid leukaemia cells are dependent on vascular endothelial growth factor (VEGF)\/VEGF receptor type2 pathway and phosphorylation of Akt","volume":"135","author":"Imai","year":"2006","journal-title":"Br J Haematol"},{"key":"key20180108012847_b21-mmr-09-02-0443","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1476-4598-7-55","article-title":"Complex molecular mechanisms cooperate to mediate histone deacetylase inhibitors anti-tumour activity in neuroblastoma cells","volume":"7","author":"M\u00fchlethaler-Mottet","year":"2008","journal-title":"Mol Cancer"},{"key":"key20180108012847_b22-mmr-09-02-0443","first-page":"593","article-title":"Inhibition of hypoxia-induced angiogenesis by trichostatin A via suppression of HIF-1a activity in human osteosarcoma","volume":"25","author":"Yang","year":"2006","journal-title":"J Exp Clin Cancer Res"},{"key":"key20180108012847_b23-mmr-09-02-0443","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0006-291X(02)02787-0","article-title":"Inhibition of hypoxia-induced angiogenesis by FK228, a specific histone deacetylase inhibitor, via suppression of HIF-1alpha activity","volume":"300","author":"Mie Lee","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180108012847_b24-mmr-09-02-0443","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1517\/13543784.10.8.1571","article-title":"Trichostatin A, an inhibitor of histone deacetylase, inhibits hypoxia-induced angiogenesis","volume":"10","author":"Williams","year":"2001","journal-title":"Expert Opin Investig Drugs"},{"key":"key20180108012847_b25-mmr-09-02-0443","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/86507","article-title":"Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes","volume":"7","author":"Kim","year":"2001","journal-title":"Nat Med"},{"key":"key20180108012847_b26-mmr-09-02-0443","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1365-4632.2006.02962.x","article-title":"Under-expression of VHL and over-expression of HDAC-1, HIF-1alpha, LL-37, and IAP-2 in affected skin biopsies of patients with psoriasis","volume":"46","author":"Tovar-Castillo","year":"2007","journal-title":"Int J Dermatol"},{"key":"key20180108012847_b27-mmr-09-02-0443","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.canlet.2008.11.012","article-title":"Targeting tumor angiogenesis with histone deacetylase inhibitors","volume":"280","author":"Ellis","year":"2009","journal-title":"Cancer Lett"},{"key":"key20180108012847_b28-mmr-09-02-0443","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/47412","article-title":"The language of covalent histone modifications","volume":"403","author":"Strahl","year":"2000","journal-title":"Nature"},{"key":"key20180108012847_b29-mmr-09-02-0443","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/38664","article-title":"Histone acetylation in chromatin structure and transcription","volume":"389","author":"Grunstein","year":"1997","journal-title":"Nature"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mmr.2013.1834\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T00:28:28Z","timestamp":1597105708000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2013.1834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,28]]},"references-count":29,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2013,11,28]]},"published-print":{"date-parts":[[2014,2]]}},"alternative-id":["10.3892\/mmr.2013.1834"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2013.1834","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,28]]}}}